Directory › Siegfried

Siegfried — Barbera Del Valles

Barbera Del Valles, Spain · CDMO

This is a record of what regulators published, not a rating.

Site facts

Company
Siegfried
Name(s) in FDA data
Siegfried Barbera, SL
FEI number(s)
3002910506 (present in FDA Data Dashboard records for this name and city)
Location (as in FDA data)
Barbera Del Valles, Spain
Records matched
3 FDA inspections · 1 recall
Most recent FDA inspection in dataset
30 Mar 2023 — VAI

Capabilities (from the company's website)

  • Highly potent (HPAPI)
    …y. It specializes in manufacturing and packaging solid oral dosage forms (OSD), including high-potency and inhalation capsules for treating respiratory diseases. Established in 1994, the site…
  • Oral solid dose
    …ts sites globally. It specializes in manufacturing and packaging solid oral dosage forms (OSD), including high-potency and inhalation capsules for treating respiratory diseases. Estab…
  • Inhalation & nasal
    …in manufacturing and packaging solid oral dosage forms (OSD), including high-potency and inhalation capsules for treating respiratory diseases. Established in 1994, the site supplies p…
  • Clinical trial supply & packaging
    …one of Siegfried’s six Drug Products sites globally. It specializes in manufacturing and packaging solid oral dosage forms (OSD), including high-potency and inhalation capsules for treatin…

Taken from the part of the company's network/locations page that describes this site. Source: https://www.siegfried.ch/company/locations/, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.

Regulatory timeline

Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.

  1. 20 Nov 2023
    Recall Class III drug recall D-0149-2024 (Completed)

    Recalling firm: Siegfried Barbera, SL, Barbera Del Valles. Reason: Failed Dissolution Specifications Product: Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Valles, Spain, Distributed by: Novartis Pharmaceuticals Corp., East Hanover, N.J. 07936, NDC 0078-1077-66

    Source: openFDA drug enforcement report (Recall D-0149-2024; FDA report date 2023-12-20)

  2. 30 Mar 2023
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002910506, inspection ID 1259929)

  3. 11 Oct 2018
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002910506, inspection ID 1090328)

  4. 18 Jul 2014
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002910506, inspection ID 888015)

This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.